IRB Compliance Program PRS Administrator, Brian Brotzman

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
ClinicalTrials.gov – How to Register Your Trial 1.
Regulation of Clinical Trials Robert Silbergleit, MD Department of Emergency Medicine NETT Clinical Coordinating Center.
Common Errors to avoid in IRB- 03 (VA) Applications.
NCI Clinical Trials Reporting Program CTRP User Meeting November 2, 2011 Gene Kraus CTRP Program Director.
FOCUS ON NLM RESOURCES: CLINICALTRIALS.GOV. WHAT IS A CLINICAL STUDY?  Research study using human subjects.  Volunteers may have a certain disease or.
NCIs Clinical Trials Reporting Program (CTRP) vs. Clinicaltrials.gov
ClinicalTrials.gov and FDAAA for NIH Extramural Grants Gwynne L. Jenkins, PhD, MPH Special Assistant to the Director Office of Extramural Programs, OER.
John Naim, PhD Director Clinical Trials Research Unit
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
A service of the U.S. National Institutes of Health Module 1: Clinical Trials and Requirements for Registration and Results Reporting.
11 February 2008NLM BOR WG on Clinical Trials1 Clinical Trials Registration and Results Reporting: Legislative Requirements Jerry Sheehan Assistant Director.
NATIONAL CLINICAL TRIAL (NCT) NUMBER Clinical Trials Management Office December 17, 2014.
 Presented By: NameTitleOffice PresentationTitle NIH Regional Seminar May 7, 2015 David Curren Special Assistant to the Office Director Officer of Policy.
MANAGING SPONSORED PROJECTS FINANCIAL COMPLIANCE May 1, 2008 Office of Grants &Contracts Accounting.
New Faculty Orientation August 22, 2012 UAMS Research Support Center Director: Tom Wells (501)
Device Clinical Trials and More… Michael E. Marcarelli, PharmD Director, Division of Bioresearch Monitoring Office of Compliance Center for Devices and.
Clinical Trial Administration Presented by: Jill Griffith and Shannon Condon.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
CTMO Lunch & Learn ClinicalTrials.gov February 24, 2015.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
AVEO PROTOCOL AV INTERACTIVE WEB RESPONSE SYSTEM (IWRS) Version 0.1 – 18 February 2011.
Guide to Academus On-Line Class Registration. Logging into Academus On-Line First, go to Then click on the Current Students tab below.
A service of the U.S. National Institutes of Health Module 3: The Librarian’s Role in Advocating to Clinical Researchers.
 Presented By: NameTitleOffice PresentationTitle NIH Regional Seminar June 26, 2014 David Curren Special Assistant to the Office Director Officer of Policy.
ClinicalTrials.gov Results Reporting, Unique Evidence, and the Role of Medical Librarians SCR CONNECTions March 19, 2014.
Sarah Faghihi Research Compliance Decision Support Analyst Office of Research Administration Faith Pottschmidt, JD Director, Clinical Trials Contracting,
CTRP User Call November 13, 2013 Gene Kraus CTRP Program Director.
Melissa McCarey, MPH Jefferson Clinical Research Institute (JCRI) Clinicaltrials.gov: What is it? What do I need to know?
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
Health Insurance portability and Accountability Act (HIPAA)‏
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
Clinicaltrials.gov Laurie A. Lebo, Ph.D
1 Session 2 Expanded Clinical Trials Registry Deborah A. Zarin, M.D. NLM Accomplishments Impact to Date Specific Data Element Issues.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
Office for Research Subjects (ORS) & Research Administration (ORA) In-Sync to Help Make your Research Happen Stephanie Gaudreau, Sr.Research Subjects Specialist,
Creating a Trip. Navigate to the UIowa website and click on “Faculty/Staff”
Research as defined by DHHS A systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable.
FIRE1000S - Self-Paced FIREBIRD Training Training on the Federal Investigator Registry of Biomedical Informatics Research Data (FIREBIRD) for Clinical.
1 ClinicalTrials.gov PL Implementation Nick Ide Chief Architect, ClinicalTrials.gov National Library of Medicine (Contractor) May 12, 2008.
Good Clinical Practice (GCP) and Monitoring Practices
ClinicalTrials.gov Jesse S. Reynolds, MS
Emily Ouellette, JD Assistant Director, Partners QI Program
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
Qualifying Clinical Trials Wendy McAtee – Research Compliance Manager
ClinicalTrials.gov Requirements
Clinicaltrials.gov Update
The Information Professional’s Role in Product Safety
NIH Clinical Trial Requirements
How to Register Your Trial
ClinicalTrials.gov: An introduction
ClinicalTrials.gov PRS – How to Register and Maintain a Record
ClinicalTrial.gov Registration & Results Requirements
Elements of an Organized Regulatory Binder
ClinicalTrials.gov Requirements
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Clinicaltrials.gov Joel Thompson, PhD COM Research Update
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Content downloaded: September 2012.
Human Subjects Office & Institutional Review Board
ClinicalTrials.gov Registration & Reporting Requirements
eResearch at Emory Phase I: eIRB
Clinical Trials Registration
IRB Compliance Program PRS Administrator, Brian Brotzman
ClinicalTrials.gov PRS – How to Register and Maintain a Record
ClinicalTrials.gov PRS – How to Register and Maintain a Record
Research Billing Compliance University of Iowa Health Care
Research with Human Subjects
Presentation transcript:

ClinicalTrials.gov Protocol Registration and Results System (PRS) for Research Coordinators IRB Compliance Program PRS Administrator, Brian Brotzman Human Subjects Office/Institutional Review Board

Overview Purpose Rules and Regulations PRS and IRB Registration Creating a Record Record Owner vs Responsible Party Record Owner Responsibilities Questions

Purpose

IT’S THE LAW!! Rules and Regulations FDAMA - Food and Drug Administration Modernization Act of 1997 FDAAA Section 801 – Food and Drug Administration Amendment Act of 2007 Final Rule (2017) IT’S THE LAW!! Penalties – Fines of up to $11,383/day Withholding of funding to the PI and the institution Potential criminal penalties

Protocol Registration and Results System (PRS) and IRB register.clinicaltrails.gov Online system for entering data to be published on the public site PRS training IRB reviews PRS records and considers them in its approval hso.research.uiowa.edu

Creating a Record Email PRS administer to create an account ct-gov@uiowa.edu Login Organization: uiowa Username: hawkid Password: you set, but PRS admin can reset, if needed Help and User Guides Flow – enrollment numbers and movement through study; Baseline – age and gender required, other variables desired.

Registration AKA ‘Protocol’ section Applicable Clinical Trial (ACT) Unique Protocol ID = HawkIRB ID Responsible Party = Sponsor-investigator Interventional vs. Observational Oversight: What is and is not an FDA regulated intervention? University of Iowa IRB 01, irb@uiowa.edu, 319-335-6564 Outcome measures Study ID – IRB#; Status – anticipated or actual; sponsor – S-I and name PI; Description – brief vs detailed; Conditions – what is being studied; Design – Interventional vs observational, phase designation; Arms – transfers to results so be sure accurate; contacts – your info.

Outcome Measure Example 1

Outcome Measure Example 2

Record Owner vs Responsible Party Record Owner – Person responsible for entering data in record Not legally responsible for record or content, but accountable for the data being entered Responsible Party – Sponsor initiating the clinical trial and responsible for the contents of the ClinicalTrials.gov record Is required by law to create, maintain, and monitor from beginning to end Significant penalties if found in non-compliance Access List

Record Owner Responsibilities Assure institutional policy is adhered to Assure information is entered accurately and consistently Assure HawkIRB and ClinicalTrials.gov records compliment each other

Institutional Policies To Remember The ‘Unique Protocol ID’ must list the HawkIRB number (digits only) The Sponsor/Collaborators section must list ‘Sponsor-Investigator’ as the responsible party type, and the PI’s name should be selected from the drop down menu Contacts should list research investigators, not IRB or administrative contacts unrelated to the trial

What Else Do We Need to Know Results Training Departmental liaisons hso.research.uiowa.edu

Questions?